pyrazines has been researched along with Blood Pressure, Low in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joseph, C; Ribeiro, A; Seikaly, M; Thach, L; Twombley, K | 1 |
| Colson, K; Doss, DS; Swift, R; Tariman, J; Thomas, TE | 1 |
| Liao, MH; Wu, CC; Yen, MH | 1 |
1 review(s) available for pyrazines and Blood Pressure, Low
| Article | Year |
|---|---|
Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications.
Topics: Anemia; Antineoplastic Agents; Asthenia; Boronic Acids; Bortezomib; Clinical Trials as Topic; Drug Approval; Drug Monitoring; Gastrointestinal Diseases; Humans; Hypotension; Multiple Myeloma; Neutropenia; Nurse's Role; Oncology Nursing; Patient Care Planning; Patient Education as Topic; Peripheral Nervous System Diseases; Protease Inhibitors; Pyrazines; Quality of Life; Thrombocytopenia; Water-Electrolyte Imbalance | 2004 |
2 other study(ies) available for pyrazines and Blood Pressure, Low
| Article | Year |
|---|---|
Acute antibody-mediated rejection in pediatric kidney transplants: a single center experience.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Boronic Acids; Bortezomib; Child; Female; Graft Rejection; Graft Survival; HLA Antigens; Humans; Hypotension; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone Hemisuccinate; Patient Compliance; Plasma Exchange; Pyrazines; Renal Insufficiency; Retrospective Studies; Rituximab; Treatment Outcome | 2013 |
Beneficial effects of tetramethylpyrazine, an active constituent of Chinese herbs, on rats with endotoxemia.
Topics: Animals; Blood Pressure; Endotoxemia; Heart Rate; Hypotension; In Vitro Techniques; Male; Medicine, Chinese Traditional; Nitrates; Nitric Oxide; Norepinephrine; Phosphodiesterase Inhibitors; Plants, Medicinal; Pyrazines; Rats; Rats, Inbred WKY; Tumor Necrosis Factor-alpha; Vasoconstriction | 1998 |